Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Current human evidence from large-scale studies has not established a clear or direct link between GLP-1 medications and thyroid cancer in humans
Phase 2 trial results, published in 2023 in the New England Journal of Medicine (Jastreboff et al., NEJM 2023), demonstrated that participants receiving the highest dose of retatrutide lost an average of approximately 24% of their body weight over 48 weeks a finding that attracted considerable attention from the medical and scientific communities
Scar Reduction: Restores skin, reduces the appearance of scars, and eliminates dark spots
Significant anti-aging and structural changes become apparent at 16-24 weeks
Per Omzo's Terms, the initial consultation and first-month supply is priced at $199 (stated as originally $179 - verify current promotional pricing at checkout)
Over time, researchers noticed additional benefits that went well beyond glucose management, including reductions in inflammatory markers and improvements in heart health indicators
US$ 27.21
US$ 21.21
US$ 22.78
